PK

Philip Krause

Mesoblast Limited | Non-Executive Director
Dr Krause has 30 years of experience at the Food and Drug Administration, he has a combination of scientific, regulatory, clinical, and public health experience. He is a physician with board certification in internal medicine and infectious diseases and a researcher with 100 publications on topics spanning clinical evaluation of vaccines, viral pathogenesis and immunology, and biological product development. He is currently an independent consultant, providing strategic and regulatory advice related to biological product development.

Company and Role

Company
Title
Tenure
Since
MSB
MSB
Mesoblast Limited
  • Non-Executive Director
4yrs, 3mthMar 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
MSB
Mesoblast Limited
30/06/25287,500N/A1,325,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MSB
MSB
Mesoblast Limited
01/04/25
Issued
785,000$1.935$1,518,975Issue of options
MSB
MSB
Mesoblast Limited
10/01/25
Issued
540,000$2.810$1,517,400Issue of options
MSB
MSB
Mesoblast Limited
09/07/24
Issued
985,000$1.095$1,078,575Issue of options
MSB
MSB
Mesoblast Limited
28/12/23
Buy
37,500$1.108$41,536On-market trade
MSB
MSB
Mesoblast Limited
05/06/23
Buy
20,000$3.705$74,100On-market trade